sanofi us
A US HEVA Rare Asset / Indication Lead at Sanofi oversees strategy and execution for the Rare Hemophilia portfolio to drive market access and commercial objectives. The role involves partner management with cross-functional teams, leading health economics research, and engaging with external stakeholders like HTA bodies to demonstrate drug value.
Headquarters
Bridgewater, New Jersey, United States
Company Size
5001-10000 employees
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for sanofi us.
4% above the average for this role
Sr. Associate – HEVA (Evidence Synthesis)
Sanofi
US Neurology and Immunology Asset/Indication Lead
Sanofi
HEVA Dupixent Business Partner Respiratory Diseases
Sanofi
Analyst - HE/HTA Specialist for the UK market - Portugal (Hybrid/Home-based)
IQVIA
Expert Scientific Writer- HEVA
Sanofi
International HEOR Lead
BridgeBio Pharma